Indoco Remedies Limited
Indoco Remedies' Chhatrapati Sambaji Nagar testing facility successfully completed a U.S. FDA Pre-Approval Inspection with zero form 483 observations. This positive outcome indicates strong compliance, which is crucial for maintaining and expanding its market reach for pharmaceutical products.
Apr 13 2026 18:04:00
Indoco Remedies Ltd - 532612 - Update On The Company''s Testing Facility At Chhatrapati Sambaji Nagar - Aurangabad
Indoco Remedies announced its Chhatrapati Sambaji Nagar (Aurangabad) testing facility successfully completed a US FDA Pre-Approval Inspection (PAI). The inspection, held from April 08-10, 2026, concluded with zero Form 483 observations, indicating full compliance and readiness for future product approvals.
Apr 13 2026 18:04:00
Indoco Remedies Limited
Indoco Remedies reappointed Joshi Apte & Associates as Cost Auditor and Suresh Surana & Associates LLP as Internal Auditor. Both appointments are for FY27, effective from April 1, 2026, ensuring continuity in audit functions.
Mar 31 2026 13:03:00
Indoco Remedies Limited
Indoco Remedies board approved the re-appointment of M/s Joshi Apte and Associates as Cost Auditor and M/s. Suresh Surana & Associates LLP as Internal Auditor for the financial year 2026-27. This ensures the continuation of essential audit functions for the company.
Mar 31 2026 13:03:00
Indoco Remedies Ltd - 532612 - Announcement Under Regulation 30 Of SEBI LODR-- Intimation Of Re-Appointment Of Cost Auditor And Internal Auditor Of The Company
Indoco Remedies' Board reappointed M/s Joshi Apte and Associates as Cost Auditor and M/s Suresh Surana & Associates LLP as Internal Auditor. Both appointments are for the financial year 2026-27.
Mar 31 2026 13:03:00
Read More